FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals (FENC) Announces Commercial Launch of PEDMARQSI In Germany
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
-
329,910 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

